Houston, TX – According to filings with the U.S. Securities and Exchange Commission, Saranas is raising $2,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Zaffer Syed played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Saranas

Saranas has developed a technology that allows for the early detection and monitoring of bleeding complications associated with vascular access procedures. The Early Bird Bleed Monitoring System includes a vascular access sheath with embedded sensors that measure the electrical resistance across the blood vessel.  By sensing a change in the vessel’s electrical resistance, the Early Bird is designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as transcatheter aortic valve replacement, large bore hemodynamic support device placement, or other complex cardiac interventions, where the femoral artery or vein is used to gain vascular access to the heart. The technology was invented at the Texas Heart Institute.

To learn more about Saranas, visit http://saranas.com/

Contact:
Zaffer Syed, President and Chief Executive Officer
650-219-4111
zaffer@saranas.com
https://www.linkedin.com/in/zaffer-syed-0854501/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved